HOME >> BIOLOGY >> NEWS
CellSearch System cleared for monitoring metastatic breast cancer

cations in the body and grow. Although there are many options for the treatment of metastatic breast cancer, oncologists often have to wait several months before they can determine if a specific treatment is beneficial to the patient. The CellSearch System helps physicians to predict if treatment is effective at any time during therapy through its ability to locate one circulating tumor cell in the 40 billion cells contained in a 7.5 ml sample of blood an achievement no other diagnostic approach has been able to accomplish.

The CellSearchTM System was cleared by the FDA in January 2004 as a diagnostic tool for identifying and counting CTCs in a blood sample to predict progression-free survival and overall survival in patients with metastatic breast cancer.


'"/>

Contact: Steve Dnistrian
908-218-8287
Veridex, LLC
15-Dec-2006


Page: 1 2

Related biology news :

1. System to analyze beating heart stem cells could lead to heart attack treatments
2. UCLAs California NanoSystems Institute partners with Abraxis BioScience
3. DOE JGI upgrades its Microbial Genome Analysis System
4. Systems characterization of cell surface receptors
5. Kent State University and Summa Health System receive NIH grant to study prehypertension
6. New Geisinger Health System building green Center for Health Research
7. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
8. Virginia Techs System X supercomputer provides super tool for simulation of cell division
9. DOE JGI upgrades IMG/M -- the Metagenomics Data Management & Analysis System
10. BioMed Central launches BMC Systems Biology, a new open access journal
11. Springer to publish new journal Systems and Synthetic Biology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: